MeSH tree: C04.557.450.565
The U.S. Food and Drug Administration (FDA) has granted accelerated approval for the immunotherapy afamitresgene autoleuecel (Tecelra, also known as afami-cel) for the treatment of adults with a rare soft tissue cancer called ...
Aug 5, 2024
0
51
A new research paper titled "Prevalence and impact of the KIT M541L variant in patients with mastocytosis" has been published in Oncotarget.
Jul 24, 2024
0
26
A new type of immunotherapy, developed by UCL researchers, has shown promising preclinical results against a bone cancer called osteosarcoma, as part of a study in mice.
May 29, 2024
0
59
Immunotherapies have revolutionized cancer treatment by harnessing the body's own immune system to attack cancer cells and halt tumor growth. However, these therapies often need to be tailored to each individual patient, ...
May 16, 2024
0
40
ChatGPT, the artificial intelligence (AI) chatbot designed to assist with language-based tasks, can effectively extract data for research purposes from physicians' clinical notes, UT Southwestern Medical Center researchers ...
May 13, 2024
0
73
Researchers at Kyushu University have developed and validated a machine-learning model that can accurately evaluate the density of surviving tumor cells after treatment in pathological images of osteosarcoma—the most prevalent ...
Apr 2, 2024
0
56
A clinical trial led by researchers at Washington University School of Medicine in St. Louis has shown that a T cell immunotherapy—in which the patients' own T cells are genetically modified to attack and kill cancer cells—is ...
Mar 28, 2024
0
50
A new research paper titled "Roles of USP1 in Ewing sarcoma" has been published in Genes & Cancer.
Feb 14, 2024
0
37
For patients with Dupuytren contracture, initial outcomes are similar for surgery, needle fasciotomy, and collagenase, but outcomes are superior for surgery at two years, according to a study published online Feb. 12 in the ...
Feb 13, 2024
0
41
Before a drug can be used to treat a disease, it must go through a lengthy and expensive trial process to prove both safety and effectiveness. By repurposing already-approved drugs, researchers can cut out the time and expense ...
Jan 12, 2024
0
47
